Efficacy and Safety of Lumateperone and Other Atypical Antipsychotics Approved as Adjunctive Treatment for Major Depressive Disorder in the United States: A Network Meta-Analysis.
Saved in:
| Title: | Efficacy and Safety of Lumateperone and Other Atypical Antipsychotics Approved as Adjunctive Treatment for Major Depressive Disorder in the United States: A Network Meta-Analysis. |
|---|---|
| Authors: | Cutler AJ; Department of Psychiatry, Norton College of Medicine, SUNY Upstate Medical University, 750 E Adams St, Syracuse, NY, 13210, USA., Lemyre A; HEOR, Analysis Group, ULC., 1190 avenue des Canadiens-de-Montréal, Tour Deloitte, Suite 1500, Montréal, QC, H3B 0G7, Canada., Zhang Q; Johnson & Johnson Innovative Medicine, 920 US-202, Raritan, NJ, 08869, USA., Mao C; Johnson & Johnson Innovative Medicine, 920 US-202, Raritan, NJ, 08869, USA. ymao11@its.jnj.com., Totev TI; HEOR, Analysis Group, Inc., 111 Huntington Ave, 14th floor, Boston, MA, 02199, USA., Gauthier-Loiselle M; HEOR, Analysis Group, ULC., 1190 avenue des Canadiens-de-Montréal, Tour Deloitte, Suite 1500, Montréal, QC, H3B 0G7, Canada., Wu Y; HEOR, Analysis Group, Inc., 111 Huntington Ave, 14th floor, Boston, MA, 02199, USA., Liu J; HEOR, Analysis Group, ULC., 1190 avenue des Canadiens-de-Montréal, Tour Deloitte, Suite 1500, Montréal, QC, H3B 0G7, Canada., Hashim M; Johnson & Johnson Innovative Medicine, Archimedesweg 4-6, 2333 CN, Leiden, South Holland, Netherlands., Namjoshi M; Johnson & Johnson Innovative Medicine, 920 US-202, Raritan, NJ, 08869, USA., Sheehan JJ; Johnson & Johnson Innovative Medicine, 920 US-202, Raritan, NJ, 08869, USA., Pilon D; HEOR, Analysis Group, ULC., 1190 avenue des Canadiens-de-Montréal, Tour Deloitte, Suite 1500, Montréal, QC, H3B 0G7, Canada., Lefebvre P; HEOR, Analysis Group, ULC., 1190 avenue des Canadiens-de-Montréal, Tour Deloitte, Suite 1500, Montréal, QC, H3B 0G7, Canada., Khoury ACE; Johnson & Johnson Innovative Medicine, 920 US-202, Raritan, NJ, 08869, USA., Citrome L; New York Medical College, 40 Sunshine Cottage Rd, Valhalla, NY, 10595, USA. |
| Source: | Advances in therapy [Adv Ther] 2026 Jun 12. Date of Electronic Publication: 2026 Jun 12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42283956 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Efficacy and Safety of Lumateperone and Other Atypical Antipsychotics Approved as Adjunctive Treatment for Major Depressive Disorder in the United States: A Network Meta-Analysis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Cutler+AJ%22">Cutler AJ</searchLink>; Department of Psychiatry, Norton College of Medicine, SUNY Upstate Medical University, 750 E Adams St, Syracuse, NY, 13210, USA.<br /><searchLink fieldCode="AU" term="%22Lemyre+A%22">Lemyre A</searchLink>; HEOR, Analysis Group, ULC., 1190 avenue des Canadiens-de-Montréal, Tour Deloitte, Suite 1500, Montréal, QC, H3B 0G7, Canada.<br /><searchLink fieldCode="AU" term="%22Zhang+Q%22">Zhang Q</searchLink>; Johnson & Johnson Innovative Medicine, 920 US-202, Raritan, NJ, 08869, USA.<br /><searchLink fieldCode="AU" term="%22Mao+C%22">Mao C</searchLink>; Johnson & Johnson Innovative Medicine, 920 US-202, Raritan, NJ, 08869, USA. ymao11@its.jnj.com.<br /><searchLink fieldCode="AU" term="%22Totev+TI%22">Totev TI</searchLink>; HEOR, Analysis Group, Inc., 111 Huntington Ave, 14th floor, Boston, MA, 02199, USA.<br /><searchLink fieldCode="AU" term="%22Gauthier-Loiselle+M%22">Gauthier-Loiselle M</searchLink>; HEOR, Analysis Group, ULC., 1190 avenue des Canadiens-de-Montréal, Tour Deloitte, Suite 1500, Montréal, QC, H3B 0G7, Canada.<br /><searchLink fieldCode="AU" term="%22Wu+Y%22">Wu Y</searchLink>; HEOR, Analysis Group, Inc., 111 Huntington Ave, 14th floor, Boston, MA, 02199, USA.<br /><searchLink fieldCode="AU" term="%22Liu+J%22">Liu J</searchLink>; HEOR, Analysis Group, ULC., 1190 avenue des Canadiens-de-Montréal, Tour Deloitte, Suite 1500, Montréal, QC, H3B 0G7, Canada.<br /><searchLink fieldCode="AU" term="%22Hashim+M%22">Hashim M</searchLink>; Johnson & Johnson Innovative Medicine, Archimedesweg 4-6, 2333 CN, Leiden, South Holland, Netherlands.<br /><searchLink fieldCode="AU" term="%22Namjoshi+M%22">Namjoshi M</searchLink>; Johnson & Johnson Innovative Medicine, 920 US-202, Raritan, NJ, 08869, USA.<br /><searchLink fieldCode="AU" term="%22Sheehan+JJ%22">Sheehan JJ</searchLink>; Johnson & Johnson Innovative Medicine, 920 US-202, Raritan, NJ, 08869, USA.<br /><searchLink fieldCode="AU" term="%22Pilon+D%22">Pilon D</searchLink>; HEOR, Analysis Group, ULC., 1190 avenue des Canadiens-de-Montréal, Tour Deloitte, Suite 1500, Montréal, QC, H3B 0G7, Canada.<br /><searchLink fieldCode="AU" term="%22Lefebvre+P%22">Lefebvre P</searchLink>; HEOR, Analysis Group, ULC., 1190 avenue des Canadiens-de-Montréal, Tour Deloitte, Suite 1500, Montréal, QC, H3B 0G7, Canada.<br /><searchLink fieldCode="AU" term="%22Khoury+ACE%22">Khoury ACE</searchLink>; Johnson & Johnson Innovative Medicine, 920 US-202, Raritan, NJ, 08869, USA.<br /><searchLink fieldCode="AU" term="%22Citrome+L%22">Citrome L</searchLink>; New York Medical College, 40 Sunshine Cottage Rd, Valhalla, NY, 10595, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228611864%22">Advances in therapy</searchLink> [Adv Ther] 2026 Jun 12. <i>Date of Electronic Publication: </i>2026 Jun 12. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Health+Communications+Inc%22">Health Communications Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8611864 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1865-8652 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220741238X%22">0741238X </searchLink><i>NLM ISO Abbreviation: </i>Adv Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42283956 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s12325-026-03630-3 Languages: – Code: eng Text: English Titles: – TitleFull: Efficacy and Safety of Lumateperone and Other Atypical Antipsychotics Approved as Adjunctive Treatment for Major Depressive Disorder in the United States: A Network Meta-Analysis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Cutler AJ – PersonEntity: Name: NameFull: Lemyre A – PersonEntity: Name: NameFull: Zhang Q – PersonEntity: Name: NameFull: Mao C – PersonEntity: Name: NameFull: Totev TI – PersonEntity: Name: NameFull: Gauthier-Loiselle M – PersonEntity: Name: NameFull: Wu Y – PersonEntity: Name: NameFull: Liu J – PersonEntity: Name: NameFull: Hashim M – PersonEntity: Name: NameFull: Namjoshi M – PersonEntity: Name: NameFull: Sheehan JJ – PersonEntity: Name: NameFull: Pilon D – PersonEntity: Name: NameFull: Lefebvre P – PersonEntity: Name: NameFull: Khoury ACE – PersonEntity: Name: NameFull: Citrome L IsPartOfRelationships: – BibEntity: Dates: – D: 12 M: 06 Text: 2026 Jun 12 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1865-8652 Titles: – TitleFull: Advances in therapy Type: main |
| ResultId | 1 |
